HK Stock MarketDetailed Quotes
02410 TYK MEDICINES-B
- 30.550
- +2.750+9.89%
Market Closed Nov 22 16:08 CST
11.33BMarket Cap-24169P/E (TTM)
30.550High28.000Low18.00KVolume28.000Open27.800Pre Close525.93KTurnover0.01%Turnover RatioLossP/E (Static)370.84MShares37.00052wk High-9.88P/B5.88BFloat Cap12.86052wk Low--Dividend TTM192.59MShs Float37.000Historical High--Dividend LFY9.17%Amplitude12.860Historical Low29.218Avg Price500Lot Size--Div YieldTTM--Div Yield LFY
TYK MEDICINES-B Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|
| Turnover | ---- | ---- | ---- | ---- | ---- | --44.24M | --44.24M |
| Operating income | 44.24M | 44.24M | |||||
| Cost of sales | ---- | ---- | ---- | ---- | ---- | ---24.2M | ---24.2M |
| Operating expenses | -24.2M | -24.2M | |||||
| Gross profit | 20.04M | 20.04M | |||||
| Administrative expenses | ---40.1M | -112.47%-21.66M | -76.83%-59.31M | -41.01%-34.22M | ---10.19M | ---33.54M | ---24.27M |
| Research and development expenses | ---137.76M | -17.68%-64.7M | -8.46%-249.25M | -28.39%-188.9M | ---54.98M | ---229.81M | ---147.12M |
| Revaluation surplus | ---47.46M | -25.50%-23.73M | -12.56%-77.79M | -15.24%-57.37M | ---18.91M | ---69.11M | ---49.78M |
| -Changes in the fair value of other assets | ---47.46M | -25.50%-23.73M | -12.56%-77.79M | -15.24%-57.37M | ---18.91M | ---69.11M | ---49.78M |
| Special items of operating profit | --11.22M | 55.46%4.67M | 57.64%25.41M | 77.88%20.88M | --3M | --16.12M | --11.74M |
| Operating profit | -214.1M | -30.02%-105.42M | -21.82%-360.94M | -37.07%-259.61M | -81.08M | -296.3M | -189.39M |
| Financing cost | ---5.43M | -10.48%-2.36M | -43.40%-22.24M | 53.47%-6.57M | ---2.14M | ---15.51M | ---14.13M |
| Earning before tax | -219.53M | -29.52%-107.78M | -22.89%-383.17M | -30.79%-266.18M | -83.21M | -311.8M | -203.52M |
| After-tax profit from continuing operations | -219.53M | -29.52%-107.78M | -22.89%-383.17M | -30.79%-266.18M | -83.21M | -311.8M | -203.52M |
| Earning after tax | -219.53M | -29.52%-107.78M | -22.89%-383.17M | -30.79%-266.18M | -83.21M | -311.8M | -203.52M |
| Minority profit | ---480K | -24.15%-257K | 8.03%-744K | 2.89%-537K | ---207K | ---809K | ---553K |
| Profit attributable to shareholders | -219.05M | -29.53%-107.52M | -22.97%-382.43M | -30.88%-265.65M | -83.01M | -310.99M | -202.97M |
| Basic earnings per share | -0.68 | -17.24%-0.34 | -17.86%-1.32 | -24.32%-0.92 | -0.29 | -1.12 | -0.74 |
| Diluted earnings per share | -0.68 | -17.24%-0.34 | -17.86%-1.32 | -24.32%-0.92 | -0.29 | -1.12 | -0.74 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- |
| Auditor | -- | -- | Ernst & Young | -- | -- | Ernst & Young | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data